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Introduction
Chondrocytes, osteoblasts, and osteoclasts are the major cell types that contribute to the development and maintenance of the skeleton (Erlebacher et al, 1995) . Vertebrate skeletons are constructed by the formation of bone and cartilage structures that can occur via two distinct mechanisms:
intramembranous and endochondral ossification. During intramembranous (or dermal) ossification, mesenchymal cells condense and differentiate into osteoblasts, the bone-forming cells. In contrast, during chondral ossification, mesenchymal cells condense and differentiate into chondrocytes to form a cartilage template. Subsequently, this template is either replaced by bone (endochondral ossification) or it becomes surrounded by bone (perichondral ossification) (Spoorendonk et al, 2010) .
The importance of runt-related transcription factor 2 (RUNX2), in skeletal development was first suggested by studies of the autosomal dominant disease cleidocranial dysplasia (CCD) (Mundlos et al, 1995; reviewed in Martin et al, 2011) . RUNX2 is a known master transcription factor for bone and hypertrophic cartilage formation expressed very early in bone development and continues to be present through the later phases of development (Ducy et al, 1997) . It is essential for osteoblast differentiation as well as a critical regulator for chondrocyte maturation (Komori et al, 1997; Otto et al, 1997; Kim et al, 1999; Inada et al, 1999; Takeda et al, 2001; Hinoi et al, 2006) . RUNX2 belongs to the Runt-related transcription factor (RUNX) family of genes which are also called core binding factor-α (CBFα). The other two members identified are RUNX1 (AML1/CBFα2/PEBP2αB) and RUNX3 (AML2/CBFα3/PEBP2αC). The RUNX proteins can bind DNA as a monomer in vitro, but their affinity for DNA is enhanced when binding to the DNA as a CBFα:β heterodimers (Ogawa et al, 1993; Wang et al, 1993) . Unlike CBFα, the CBFβ subunit does not contact DNA directly, but rather stabilizes and enhances in vitro DNA binding of the runt domain of the α subunit (Ogawa et al, 1993; Wang et al, 1993) , which is a DNA binding domain conserved amongst the Runx family (Ogawa et al, 1993) . Earlier studies have indicated that CBFβ and RUNX2 can cooperatively activate transcription (Harada et al, 1999; Zhang et al, 2000) . Kundu et al (2002) carried out a series of experiments to determine whether CBFβ and Runx2 could interact physically and function in a cooperative manner, and have shown that the addition of CBFβ strongly induced the DNA binding of Runx2 (Kundu et al, 2002) .
Runx2 initiates and mediates the entire process of hypertrophic differentiation of chondrocytes (Stricker et al, 2002; Smith et al, 2005 ) by regulating the transcription of genes important for this process, e.g. collagen type X gene (Col10α1) (Enomoto et al, 2000; Zheng et al, 2003; Higashikawa et al, 2009) . RUNX2 regulation of cell-specific Col10α1 expression may impact the process of chondrocyte maturation and represent the major mechanistic basis of multiple skeletal pathologies, such as CCD, fracture healing, and osteoarthritis (Higashikawa et al, 2009; Zheng et al, 2005; Kamekura et al, 2006; Tu et al, 2007) . Zheng et al (2005) have previously reported abnormal endochondral ossification in a fetal case of CCD, possibly due to altered RUNX2 regulation of chondrocyte hypertrophy and down-regulation of its target genes, including type X collagen. The above observations clearly demonstrate that both Runx2 and Col10α1 genes play important roles upon chondrocyte maturation during endochondral bone formation. The interaction between Runx2 and the Col10α1 proximal or core promoters in different species has previously been described extensively (Dourado and LuValle, 1998; Zheng et al, 2003; Simões et al, 2006; Higashikawa et al, 2009 ).
Most studies in the areas of osteogenesis and mineral research have been performed in mice and chicken, or using in vitro cell culture systems. Although it has been shown that there are some characteristics in teleost bones that differ from mammals (Witten and Huysseune, 2009) , the origin of cells that contribute to the various bone elements and the key regulators of bone formation are highly conserved between mammals and teleosts. Furthermore, the corresponding orthologs share significant sequence similarities and an overlap in expression patterns (Flores et al, 2004; Yan et al, 2005; Li et al, 2009 ) when compared to mammals. As a result of this finding, in the last few years zebrafish was demonstrated to be a powerful model especially in forward genetics to identify novel gene functions and to study their role in numerous processes including osteogenesis. Accordingly, zebrafish can be used as a tool to complement genetic and embryological studies in mice and chicken in order to clarify the molecular mechanisms underlying bone development and disease. In addition, zebrafish and medaka are ideally suited and currently the only model systems available to allow visualization of chondrocytes and osteoblasts in vivo over time.
Thus far, different CBFβ isoforms have been described in mammals, but just one zebrafish Cbfβ protein has been reported. Here we report the cloning and characterization of ten novel zebrafish isoforms, which are generated by alternative splicing. A structural conservation during evolution from fish to mammals was confirmed, by a comparative analysis between zebrafish cbfβ gene and protein and its orthologs in different species. Previously, we have shown that zebrafish col10α1 expression is up-regulated by Runx2 (Simões et al, 2006) through its binding to specific motifs within the col10α1 promoter region. So, we tested the ability of some of these newly identified Cbfβ isoforms to enhance Runx2-dependent up-regulation of col10α1 promoter. The transcriptional activity determined by luciferase reporter assays was enhanced by transfection of Runx2-MASN isoform and increased even more potently by the co-transfection of both Runx2-MASN and the co-activator Cbfβ (isoforms 1 and 2) as compared with the control. Furthermore, this indicates that Cbfβ exon 5a is not required for interaction with Runx2-MASN and transcription activation. Moreover, we analysed the expression pattern of the Cbfβ isoforms 1 to 4 in various adult tissues and at different embryonic developmental stages.
MATERIALS AND METHODS

Zebrafish RNA extraction and RNA reverse transcription
Total RNA was extracted from ZFB1 cell line as described by Vijayakumar et al (2013) and from pools of zebrafish embryos at different stages of development and from a variety of adult zebrafish tissueswith TRIzol (Sigma-Aldrich) as recommended in the manufacturer's protocol. RNA
Genomic structure of zebrafish and human CBFβ gene
Exon-intron architecture of zebrafish cbfβ gene was determined through mRNA-to-genomic alignment using Zv9 zebrafish genome assembly and transcript sequences determined within the scope of this work. Similarly, human gene structure was determined using GRCh37 genome assembly, mRNA and expressed sequence tag (EST) sequences retrieved from NCBI (on 2014-04-13).
Assessment of conserved synteny
To examine patterns of conserved synteny, chromosomal loci of CBFβ genes in human, and zebrafish were compared by identifying all neighbour genes of CBFβ. The position of each of these genes was searched in both species using the Ensembl database search function.
Isoform expression profile
To determine the presence of the Cbfβ alternative transcripts (isoforms 1 to 4) during various zebrafish developmental stages and in a broad number of adult tissues, primers were designed in order to amplify all the four splice variants. A first RT-PCR amplification was performed with the primers CBFβ_F3 and CBFβ_R3 (Table 1) . Then, 1µl of the first amplification product was used to perform a second amplification with the CBFβ isoforms 1 and 2 specific primers (CBFβ_F3 and CBFβ_R5; Table 1 ) and the CBFβ isoforms 1 and 3 specific primers (CBFβ_F4 and CBFβ_R3; Table 1 ). The zebrafish gadph was used as control (Gapdh_F and Gapdh_R; Table 1 ). The RT-PCR amplification was performed with the DreamTaq PCR Master Mix (Thermo Scientific) in a 25µl reaction for 40 cycles.
Plasmid construction
The zebrafish collagen Xα1 luciferase reporter plasmid [4x(-822/-794)TATALuC] and zfrunx2 P1-MASN (til-1ORF-pCMX-PL1) were previously described (Simões et al, 2006) .
The expression vectors of the full length and splicing variants of zebrafish cbfβ (cbfβ isoform 1 to 4) were obtained by cloning all the corresponding open reading frames into the pCMX-PL2 expression vector (kindly provided by Dr. R. Schüle laboratory).
The zebrafish HA-tagged cbfβ and and Flag-tagged runx2 expression constructs (pcDNA3.1-HAcbfβ isoform 1 to 4 and pcDNA3.1-Flag-runx2 P1-MASN) were generated by subcloning PCRamplified full-length cbfβ isoform 1 to 4 and runx2 P1-MASN cDNAs into the BamHI and XbaI sites of a pcDNA3.1 expression vector containing at the N-terminal portion of the proteins.
All constructs were verified by DNA sequencing. Plasmids used for transfection studies were prepared using the plasmid GFX™ Micro Plasmid Prep kit (GE Healthcare).
Cell transfection and luciferase assays
Human embryonic kidney (HEK) 293 cell line (ATCC number CRL-1573) was cultured in 
Co-immunoprecipitation (Co-IP) Assay
For co-immunoprecipitation assays, ~0.1-0.2 mg of whole cell extracts from HEK293T cells transfected with expression vectors for the four HA-CBFβ isoforms alone or together with FLAG-Runx2, were prepared in buffer containing 50 mM Tris pH7.5, 150 mM NaCl, 1% Triton-X100, and
Complete protease inhibitors (Roche), and incubated with M2 Flag-resin (Sigma) overnight at 4 °C.
The resin was washed five times with wash buffer (20 mM Tris pH 7.5, 100 mM NaCl, 0.1 mM EDTA, 0.05% Tween-20) and the bound material was eluted with 200 μg/ml solution of flag peptide (Sigma), for 30 minutes at 4ºC. Samples were subjected to western blot analysis.
Western Blot Assay
For western blot assays, protein extracts were subjected to 12% SDS-PAGE, and thereafter transferred onto a PVDF membrane (GE Healthcare) with a semi-dry blot system (BioRad). Mouse monoclonal 16B12 antibody against HA epitope (Covance) was used at 1:2000 dilution and anti-flagM2 (Sigma) antibody was used at 1:5000 dilution. Blotted proteins were visualized using horseradish peroxidase-conjugated goat anti-mouse (Southern Biotech), the chemiluminescence blotting substrate detection system from Roche and X-ray films.
Statistical analysis
The data was presented as average and standard deviation of measurements taken at least in three separate experiments. Statistical significance of data was determined wherever indicated by analysis of variance (ANOVA) followed by a Tukey test for multiple comparisons within a group. Differences were considered to be significant at p<0.001.
Results
Molecular cloning of novel spliced variants of zebrafish cbfβ
Using a combination of bioinformatics and RT-PCR approaches, we cloned a cDNA fragment encoding the zebrafish cbfβ open reading frame (ORF). Sequencing predicts an ORF of 564 bp encoding a 187 aa polypeptide. From the cDNA deduced primary structure, we identified the typical CBFβ domain characteristic of this family of proteins, and sequence comparison with the available zebrafish cbfβ cDNA (accession number: NM_199209.1) showed 100% identity. This isoform was named in this work as isoform 4. So far, just one transcript has been described for the zebrafish cbfβ gene, contrasting with mammals where two major transcripts have been described for this gene that generate two different protein isoforms with a different C-terminal sequence.
In the course of amplifying the cDNA for the entire ORF of zebrafish cbfβ using RT-PCR, we observed multiple amplified products. By cloning and sequencing each one of them we were able to identify ten novel transcript variants for zebrafish cbfβ that are described here for the first time.
Figure 1
shows both the simple and compound deletion events discovered in this study. These transcripts result from alternative exon skipping, generating different protein isoforms, depending on the splicing event. The identity of the cbfβ cDNA sequences obtained was confirmed using blast searches against GenBank (NCBI). The nucleotide sequences of these new spliced variants were deposited in GenBank as cbfβ isoforms 1 through 11 (GenBank ID: KF709194, KF709195, KF709196, KF709197, KF709198, KF709199, KF709200, KJ704807, KJ704808, KJ704809 and KJ704810, respectively).
The transcript cbfβ isoform 1 corresponds to the longest transcript we cloned and has an additional 90 nucleotides compared to the cbfβ transcript described previously (Figure 1) . This extra nucleotide sequence in cbfβ isoform 1 within the 3′ coding region generates a stop codon located in exon 5b, resulting in a protein isoform with a different C-terminal sequence from the form described previously (Figure 2) .
The transcripts of cbfβ isoform 2 and 3 are spliced variants generated by skipping exon 5a (i.e. a 42 bp fragment) or 5b (i.e. a 48 bp fragment), respectively. The resulting protein products of these alternative splicing variants are similar to cbfβ isoforms 1 and 4, respectively, in terms of the stop codon used (Figure 1) . All the cbfβ isoforms 1 to 4 preserve the heterodimerization domain intact, suggesting that they produce functional proteins.
Interestingly, we found two predicted isoforms similar to the cbfβ isoform 1 and 2 in the NCBI database (XM_005159048.1 and XM_005159049.1), supporting together with our results the existence of these alternative splicing isoforms in zebrafish cbfβ.
The transcripts cbfβ corresponding to the isoform 5, 6 and 7, are generated by a complex splicing of multiple sequence fragments from different exons, resulting in truncated isoforms, lacking an extensive part of the characteristic CBFβ heterodimerization domain. As a consequence, all of these cbfβ transcripts are likely to result in loss-of-function mutants.
The transcript cbfβ isoform 8 results from an alternative splicing event that involves a partial deletion of the exon 6 (5 bp). This deletion is in the 3' UTR and does not affect the coding region, so the predicted protein isoform is exactly the same as the one produced by cbfβ isoform 1.
The transcript cbfβ isoform 9 is also similar to the cbfβ isoform 1, differing only in a deletion of three nucleotides in the beginning of exon 5a and expected to result in deletion of one amino acid (Q166) from the encoded protein. Interestingly, an isoform similar to the cbfβ isoform 9 was recently submitted to the NCBI database as a predicted isoform (XP_005159104.1), but presenting the splicing of the exon 5b in addition to the 3 nucleotides deletion we characterized.
The cbfβ isoform 10 harbours both the deletion of the 3 nucleotides present in cbfβ isoform 9 as well as the deletion of the 5 nucleotides observed in cbfβ isoform 8. This isoform presents also the complete deletion of exon 2 (Figure 1) . Since exon 2 codes for part of the heterodimerization domain, we hypothesize that this change leads to loss of function of this isoform.
The new transcript cbfβ isoform 11 has a splice starting at the 3'-end of exon 3 (pΔ3 51 bp) and utilizes a splice acceptor site within exon 6 instead of the "native" acceptor site. Analysing the cDNA sequence obtained for this isoform, we observe that this deletion event causes an out-of-frame translation and furthermore, introduces a stop codon after the alternative splicing (in exon 6) that is located 67 nucleotides downstream the annotated stop codon for the cbfβ, thereby introducing a late termination of protein translation, resulting in a protein isoform with a different C-terminus sequence.
Summarizing, we found in this study simple exon-skipping events that can be categorized as follows:
(a) simple deletions, that is skipping of complete single exons or consecutive exons (for example, Δ5a; Δ5b; Δ5a,5b; isoforms 2-4, respectively) and (b) partial exon deletions (for example, pΔ6 5 bp; pΔ5a 3 bp; isoforms 8 and 9). In addition to the five simple exon-skipping events shown in Figure 1 , five more splicing events were identified that involved multiple exon-skipping events. In these compound exon-skipping transcripts, several splicing events were evident from the pre-mRNA processing (Figure 1) . These compound splicing events include combinations of the whole exonskipping and partial exon deletion (pΔ3 56 bp, pΔ4 42 bp plus Δ5a; pΔ1 39 bp, Δ2, pΔ3 85 bp, plus Δ5a; pΔ1 39 bp, Δ2,3, pΔ4 27 bp, Δ5, plus pΔ5a 18 bp; Δ2, plus pΔ5a 3 bp plus pΔ6 5 bp; pΔ3 51 bp, Δ4, 5,5a,5b plus pΔ6 69 bp; isoforms 5-7, 10 and 11). These multiple exon skipping events all involved the entire or partial deletion of exon 5a, which implies that the skipping of this exon is a common event in the pre-mRNA processing.
As mentioned previously, we identified in this study alternative splicing events that involve partial exon deletions instead of the skipping of complete exons. The splice sites used are shown in Table   2 . Three of these variants (isoforms 9 and 10, pΔ5a 3bp and isoforms 8 and 10, pΔ6 5bp) still keep their original splicing donor site (GT) in the boundary of the exon and intron but utilize the next possible legitimate splice acceptor site (AG) within the exon in the immediate vicinity area, instead of the 'native' acceptor site. These two partial deletion events do not cause out-of-frame translation and, furthermore, they use the same stop codon as the full transcript (isoform 1). The splicing events of the other four variants (isoforms 5, 6, 7 and 11) are more complex. In the partial deletions pΔ3-4 (isoform 5) and pΔ1-4 (isoform 7) not only are none of the original splice donor/acceptor sites used, but those that are used are very atypical ( Table 2) . For the remaining variants pΔ1-3 (isoform 6) and
pΔ3-6 (isoform 11), do not use a pair of legitimate splice donor site within exon 1 (isoform 6) or exon 3 (isoform 11) but utilize the next possible legitimate splice acceptor site (AG) within the exon 3 (isoform 6) or exon 6 (isoform 11), instead of the 'native' acceptor site, causing a 211 bp (isoform 6) or a 423 bp (isoform 11) deletion.
Translation potential of the cbfβ spliced variants
The predicted protein sequences translated from these alternative spliced transcripts are summarized in Figure 2 . Two of these variants (isoforms 5 and 6) introduce early termination codons to the open reading frames after the alternative splicing event(s), which may produce premature proteins with only short peptides (94 aa and 26 aa, respectively) of Cbfβ.
Chromosomal localization and structural organization of the zebrafish cbfβ gene and cDNA
Chromosomal assignment of the zebrafish cbfβ gene was performed by BLAST against NCBI database. The zebrafish major cbfβ transcript cloned (isoform 1) was aligned with the zebrafish genomic sequence, and sites of exon-intron borders were deduced by comparison. The zebrafish cbfβ gene was found on chromosome 18 (position 22774824-22852021) with a length of approximately 77.200 kb, and based on the data in this study it is organized in 8 exons and 7 introns (Figure 3) . All splice junctions follow the GT/AG rule (Breathnach and Chambon, 1981) . The zebrafish cbfβ isoform 1 contains all eight exons (exons 1 to 6, including exons 5a and 5b) with the start codon in exon 1 and the termination codon in exon 5b, and exon 6 contains the 3´ UTR. The protein deduced from this major Cbfβ isoform is 188 amino acids long. It contains a heterodimerization domain of 135 amino acids starting with the first methionine, and spanning sequences from exon 1 through exon 4.
Protein sequence alignment between zebrafish and orthologs
Sequence databases at NCBI (www.ncbi.nlm.nih.gov) were searched for annotated CBFβ sequences.
A total of 59 CBFβ sequences (containing the complete coding sequence) were collected. The full collection of sequences represents 29 species, including most classes of vertebrates (mammalia, sauropsida, amphibia, chondrochthyes and actinopterygii). Although this analysis was performed using sequences from a large set of organisms with diverse evolutionary pathways, CBFβ alignment revealed a remarkable conservation of protein primary structure (Figure 4) , confirming the existence of domains in the protein that are highly conserved. Interestingly, we found four different protein isoforms (labelled A to D) that differ only in the C-terminal region (Figure 4) (Figure 4 and results not shown).
The residues from 166 to 174 in Cbfβ_C were encoded by exon 5b, that contains the stop codon. We also observed the presence of a C-terminal that is different from the named Cbfβ_A or Cbfβ_C that we called Cbfβ_B and was only found in Sarcopterygii, which is obtained from a long exon 5 (more 31 bp in the 3´-end) that ends in the exon 6 coding for the seven last amino acids and the stop codon.
A fourth variant named Cbfβ_D has been identified in fish (all neoteleostei: Amazon molly, Nile tilapia, zebra mbuna, Burton´s mouthbrooder and red Mwanza) (Figure 4 and results not shown), that results from the occurrence of an alternative splicing from exon 5 to a cryptic site in exon 6. The transcription of exons 1, 2, 3 and 4 does not undergo any modifications and remains constant. We have calculated the pair-wise percentage identities among all CBFβ protein sequences used in this study, and we can observe a high identity between all the species (Table S1) , even if we take in account the C-terminal differences observed in the alignment.
Conserved gene synteny of zebrafish cbfβ gene
Synteny-based analysis of zebrafish cbfβ gene shows strong syntenic conservation between human chromosome 16 and zebrafish chromosome 18. In both cases, the genes DNAJA2L, BBS2, GOT2, CCDC79, PDP2, CES2, CES3, B3GNT9, HSF4, PARD6A, TSNAXIP1, NUTF2, EDC4, PSKH1, NRN1LA, CIRH1A, AARS, TAT, BCAR1, NOC4 and KIAA1049 were found in the region of CBFβ gene, but they appear in a different order ( Figure 5 and Table S2 ). Interestingly, from this list of genes only noc4 and kiaa1049 are present downstream side of cbfβ gene in zebrafish chromosome 18 ( Figure 5) . This syntenic conservation supports the identification of cbfβ as ortholog to human CBFβ.
Expression profiles of zebrafish cbfβ variants
Expression patterns of cbfβ mRNA variants were analyzed using RT-PCR with gene-specific primers located on ORF exons and variant-specific primers located on respective leader/terminal exons (Figure 6) . To assess the expression of the zebrafish cbfβ transcript variants, the coding region between exons 5 and 6, comprising the full and the alternatively splicing exons 5a and 5b were amplified (Figure 6A) . The cbfβ mRNA was widely distributed. In a first PCR round the amplification of all four possible splicing variants (isoforms 1 to 4) was tested using the primers CBFβ_F3 and CBFβ_R3 located in exon 5 and exon 6, respectively. Two amplicons corresponding to isoform 1 (199 bp) and isoforms 2 and/or 3 (157 bp and 151 bp, respectively) were observed in all samples tested (Figure 6B) . A third amplicon corresponding to isoform 4 (109 bp) was observed in all tissue samples and developmental stages tested, except at 1 cell stage. In order to distinguish the expression of isoform 2 and 3, a second amplification was performed with isoform specific primers.
The expression of isoform 2 mRNA was analyzed using a forward primer located on the exon 5 and a reverse primer on exon 5b (Figure 6A) . This amplification generates two amplicons corresponding to isoform 1 (138 bp), and isoform 2 (96 bp). It was observed that the isoform 2 is expressed in all the developmental stages and tissues analysed (Figure 6B) . The expression of isoform 3 mRNA was analysed using a forward primer located on the frontier of exons 5/5a and a reverse primer on exon 6, resulting in two amplicons corresponding to isoform 1 (151 bp) and isoform 3 (103 bp). The expression of isoform 3 was observed in all the developmental stages and tissues analysed with the exception at 1 cell stage where the corresponding amplicon was not observed (Figure 6B ).
Functional analysis of the different cbfβ splicing variants
Given that CBFβ is a transcription co-factor, and is able to bind mammalian CBFα proteins and enhance their DNA binding affinity (Wang et al, 1993) , we wanted to test if the zebrafish Cbfβ protein isoforms cloned in this work had a similar function. The newly identified isoforms 1 to 3, and also the isoform 4 that corresponds to the one previously characterized (AF278758) were cloned in an expression vector and used in co-transfection assays with a fragment of the zebrafish col10α1 promoter described previously (Simões et al, 2006) . This promoter was previously reported to be regulated by the Runx2 transcription factor (zebrafish isoform MASN-Runx2) (Simões et al, 2006) .
To this end, HEK293 cells were transiently co-transfected with the pTATALuC-4×ColX(-822/-794) vector containing four repeated copies of the Runx2 binding site, in the presence of expression vectors containing MASN-Runx2 and the zebrafish cbfβ isoforms 1 to 4. Our previous studies showed that in the Xenopus laevis A6 cell line the transcriptional activity of the pTATALuCColX (-822/-794) construct is induced by MASN-Runx2 isoform, and a further increase was observed when four copies of this sequence element were present (Simões et al, 2006) . In the present work we showed in HEK293 cells that the ability of MASN-Runx2 to transactivate the 4×ColX construct, although smaller than previously seen in A6 cells, was strongly stimulated when Cbfβ isoforms 1 or 2 were co-expressed (Figure 7) . Furthermore, Cbfβ isoforms 3 and 4 seem to have lost the ability to regulate Runx2 (Figure 7) . All together, these results clearly indicate that the presence of the different amino acids in the C-terminal of the Cbfβ that are generated by the presence of the exon 5b, are likely to be essential for protein binding to Runx2-MASN isoform and so to enhance Runx2-induced transcription. We also show that Cbfβ alone has no effect on 4×ColX transcription (Figure 7) .
Co-immunoprecipitation of Cbfβ splicing variants and runx2
To assess the heteromeric assembly of zebrafish Cbfβ protein isoforms 1 to 4 and Runx2 by an independent biochemical approach, co-immunoprecipitation experiments were performed. Protein lysates prepared from HEK293 cells expressing HA-tagged Cbfβ isoforms 1 to 4 alone or together with Flag-tagged runx2 were immunoprecipitated with an anti-Flag monoclonal antibody.
Immunoprecipitates were subjected to SDS-gel electrophoresis and probed with anti-HA and anti-FLAG antibodies to visualize HA-Cbfβ isoforms 1 to 4 and Flag-Runx2 (Figure S1) . Flag-Runx2 was specifically co-immunoprecipitated with HA-tagged Cbfβ isoforms 1, 2 and 4, but not HA-Cbfβ isoform 3 (Figure S2) . These experiments clearly indicated that Cbfβ isoforms 1, 2 and 4 are present in protein complexes with Runx2 in HEK293 cells, suggesting an interaction between these isoforms and Runx2, while the isoform 3 of Cbfβ failed to interact with Runx2 under these conditions.
Discussion
In this study we describe 11 different spliced variants of zebrafish cbfβ mRNA (including the one previously known (Blake et al, 2000) corresponding to our isoform 4, Δ5aΔ5b). These 10 novel spliced variants greatly expand our knowledge of the isoforms of cbfβ at the level of mRNA in zebrafish and provide evidence for a conserved structure and splicing events between zebrafish and human CBFβ genes. Alternative pre-mRNA splicing plays an important role in regulating gene expression by generating multiple transcripts from a single gene with specific spatial and temporal patterns, thus contributing to generate proteome diversity and increasing flexibility for gene expression and regulation (Graveley, 2001; Black, 2003) . Nonetheless, much remains to be understood about the mechanisms and functional significance of this process. The CBFβ gene encodes a transcription factor (CBFβ) that plays important roles in hematopoiesis, osteogenesis and leukemia (Liu et al, 1995; Speck et al, 1999; Miller et al, 2002) . The biological relevance of CBFβ has been demonstrated in a knock-out mouse model that exhibits embryonic lethality due to defective fetal liver hematopoiesis and central nervous system bleeding, recapitulating the Runx1 null phenotype (Sasaki et al, 1996; Wang et al, 1996) . Conversely, heterozygous Cbfβ +/knock-in mice survive gestation but die soon after birth with bone developmental defects comparable to those observed in Runx2 -/mice although less severe (Kundu et al, 2002) . In zebrafish, cbfβ is expressed during embryogenesis in early hematopoietic cells and in the lateral plate mesoderm at tail bud stage, as well as in Rohon-Beard cells, cranial nerve ganglia, hindbrain, retina, branchial arches, jaw, and fin buds (Blake et al, 2000) . Recently it was shown that zebrafish cbfβ knockout mutants (cbfβ -/-) retained primitive hematopoiesis and erythro-myeloid progenitors but completely lacked all definitive blood lineages (Bresciani et al, 2014) , confirming the importance of Cbfβ in the onset of definitive hematopoiesis. Our RT-PCR analysis in zebrafish developmental stages and adult tissues shows that cbfβ is widely expressed, been detected in all samples analyzed. This is in agreement with a previous study (Blake et al, 2000) where they show by Northern blot hybridization that cbfβ expression is first detected at 3-somite stage and then continued through to at least 48 hpf and also in an adult sample.
Our gene expression profile data demonstrate that at 1 cell stage just the cbfβ isoforms 1 and 2 are detected, but not isoforms 3 and 4 ( Figure 6B) . The fact that isoforms 1 and 2 are detected at 1 cell stage indicates that they are maternally inherited, in contrast to isoforms 3 and 4 that are not expressed at this time, emphasizing that the biological function of Cbfβ splice variants should be further evaluated throughout development. Blake and co-workers (2000) also showed that cbfβ is expressed in the kidney as they used a kidney cDNA library to clone the transcript. Our data shows that cbfβ expression persists in adult, as we could detect all four transcript variants (isoforms 1 to 4) in all the tissues analyzed (Figure 6B) .
Translated variants of such an important mRNA species may have important modulatory functions in development or in critical cell fate decisions, although some of these isoforms may not be translated due to the process of nonsense-mediated mRNA decay (NMD) that promotes degradation of mRNAs containing premature translation termination codons. This process was identified and studied also in zebrafish, and shown to be essential for zebrafish embryonic development, preventing accumulation of potentially detrimental truncated proteins (Wittkopp et al, 2009 ). Two of the transcript variants described in this report present premature termination codons (isoforms 5 and 6; Figure 1) , and thus may be potential targets for the NMD pathway, and not likely to be translated into protein.
In human and mice, CBFβ resides on chromosomes 16 and 8, respectively, and both species show two major isoforms resulting from distinct alternative splicing events that produce, in each case, a frame-shift generating a termination codon so that the two proteins (of 187 and 182 amino acids, respectively) differ in several amino acids at the carboxy terminus Ogawa et al, 1993 ) (Figure S3) . A search of the human dbEST and non-redundant data bases identified three more exons in the human CBFβ gene (Figure S4) , giving a gene structure of nine exons whose alternative splicing creates ten human CBFβ isoforms.
Multiple alignments between major CBFβ isoforms described in different vertebrates (Figure 4 and   Figure S5 ), show that zebrafish Cbfβ_A (isoform 4) is highly conserved in all species analysed (CBFβ_A isoform containing 187 aa). In contrast, the C-terminal of the zebrafish Cbfβ_C (isoform 2) shows high homology with the C-terminal of Cbfβ from other fish (e.g. Atlantic salmon, tilapia, and medaka isoform_C) but differs from the C-terminal of the other vertebrates CBFβ_B (isoform containing 182 aa) used in the alignment. This divergence in the C-terminal between the different species may indicate that this region has a functional relevance that could be species specific, possibly mediating interactions with different proteins from the CBF regulatory complex. Different groups (Wang et al, 1996; Kagoshima et al, 1996; Zhou et al, 2012; Du et al, 2013) have studied the CBFβ binding capacity to Runx co-factors throughout the heterodimerization domain (N-terminal region), but the exact function of the C-terminal region of the CBFβ isoforms is still unknown at this time.
Interestingly, an association between breast cancer and mutations in the heterodimerization domain of CBFβ were previously reported (Banerji et al, 2012; Taniuchi et al, 2012; Ellis et al, 2012) .
Accordingly, all these CBFβ genetic changes are likely to result in loss-of-function mutants.
Oncogenic rearrangements of CBFβ are common in acute myeloid leukaemia where the CBFB-MYH11 translocation produces a protein product that fuses the first 165 aa of CBFβ to the MYH11 resulting in a hybrid molecule believed to have dominant negative function (Shigesada et al, 2004) .
It was previously shown that Cbfβ interacts with Runx2 in bone and cartilage and enhances Runx2mediated transcription (Kundu et al, 2002; Yoshida et al, 2002; Nakashima and Crombrugghe, 2003; Kanatani et al, 2006; Han et al, 2010) . Higashikawa et al (2009) showed that human COL10A1 promoter activity, which was enhanced by RUNX2, was further potentiated by RUNX2 in combination with the co-activator CBFβ. The same was observed with the osteocalcin promoter (Kanatani et al, 2006) . According to previous studies, the C-terminal amino acids that are different between the two major CBFβ isoforms are in a region of the protein that is not required for the heterodimerization with the RUNX partner (Ogawa et al, 1993; Kagoshima et al, 1996) and so it was suggested that the amino acid differences in this region are not expected to affect the ability of the α/β subunits to heterodimerize (Blake et al, 2000) . From the spliced variants cloned in this work, four of them seem to be potentially interesting from a functional point of view: isoforms 1 to 4 (the complete, Δ5a, Δ5b and Δ5aΔ5b isoforms, respectively), and so their capacity for transcription transactivation was further analysed. Our co-transfection experiments demonstrate that zebrafish Cbfβ isoforms carrying the exon 5b (isoforms 1 and 2) have a higher capacity to enhance the induction of ColX promoter by Runx2-MASN isoform, compared to the isoforms lacking exon 5b (isoforms 3 and 4) (Figure 7) . Immunoprecipitation data allowed us to explain the transactivation data by the direct interaction of Runx2 with Cbfβ isoforms 1 and 2 and not with Cbfβ isoform 3. However, an interaction was also observed between Runx2 and Cbfβ isoform 4, although this interaction does not result in a Runx2 stimulated transcription of ColX promoter in the conditions tested. The differences between these four Cbfβ isoforms reside in their C-terminal region (Figure 2) . Isoforms 1 and 3 have distinct C-terminal sequences, while isoforms 2 and 4 represent spliced variants of isoforms 1 and 3, respectively. These results suggest that isoforms 1 and 2 have a functional motif that is lacking in isoforms 3 and 4, likely located in exon 5b. Alternatively, the distinct C-terminal domain found in isoforms 3 and 4, (Figure 2 ) may be interfering with its binding to the Runx2 protein by either affecting the stabilization of the heterodimer, enabling the binding of some other co-factor still not identified and important to the function of the CBF complex, or affecting its translocation to the nucleus, which is required for acting as a co-factor of Runx2.
Zebrafish Cbfβ (isoform 4; Δ5aΔ5b) has previously been shown to induce the human CBFα2
(RUNX1-MRIPV isoform) as efficiently as the human CBFβ protein (isoform 187) (Blake et al, 2000) . In contrast with these findings, our results show no significant enhancement of runx2-MASN transcriptional activity in the ColXα1 promoter fragment when co-transfected with the Cbfβ isoform 4 (Figure 7) . This apparent discrepancy may indicate that the different CBFα subunits (runx1, 2 and 3) have distinct affinities for the different Cbfβ isoforms. In fact, it was shown that in mammals the CBFβ (isoform 187) and CBFβ (isoform 182) interact with RUNX1 similarly, although CBFβ (isoform 187) in conjunction with RUNX1 transactivates SL3-3MLV enhancer more strongly (Zaiman et al, 1995) . In addition, and as suggested previously, CBFβ proteins apart from their well-known function as co-factors of RUNX associated DNA-binding affinity, may have additional functions such as, (i) when bound to the runt domain, CBFβ proteins may induce a conformational change allowing it to interact with other transcriptional activators or (ii) it can act as an interacting factor between RUNX proteins and other protein cofactors Li and Gergen, 1999) . Altogether it seems that CBFβ isoforms function can be modulated by the RUNX isoform present and thus also depends on the cell type used in each study (Adya et al, 1998) . Higashikawa et al (2009) showed that the effect of RUNX2 in human COL10A1 promoter activity observed in human cells were not reproducible in the mouse chondrogenic ATDC5 cells, in which neither RUNX2 alone nor in combination with CBFβ affected COL10A1 promoter activity. Indeed, more recently Du et al (2013) showed that when HEK293T cells were co-transfected with the C-terminal-truncated CBFβ constructs and the viral infectivity factor (Vif) of HIV-1 (Vif-expressing vector) following repression of endogenous expression of CBFβ by an shRNA approach, Vif expression appeared quite variable, depending on the co-transfected CBFβ variant. The authors concluded that different lengths of CBFβ are required for its role in Vif function and for its role in RUNX-mediated gene transcription and hypothesized that different CBFβ domains may be required for regulation of different target genes (Du et al, 2013) . It is also possible that still another co-activator, as yet unidentified, may be involved in this process of transactivation but further studies are required to clarify the precise mechanism of this phenomenon.
Overall, in this work we have cloned and described for the first time a variety of zebrafish cbfβ alternative spliced variants. Using a bioinformatic approach we have determined the structures of both the zebrafish cbfβ gene and predicted protein products and shown a high degree of sequence identity between zebrafish Cbfβ and the mammalian CBFβ proteins, indicating conserved function(s).
Using luciferase assays, we showed that the Runx2-MASN mediated activation of the Col10α1 promoter is differentially co-activated by Cbfβ isoforms, although further work will be needed to clarify the significance of the biological function of these cbfβ variants. Numbering is according to the first residue of the protein. 
